Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest

Dermatologic Surgery

Volumn 28, Issue 1, 2002, Pages 46-51

  Bowes, Leyda E ^a   Goldman, Mitchel P ^b  

^a Dermatology Associates of San Diego County Inc   (United States)

^b Laser and Skin Surgery Center of La Jolla   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DETERGENT; POLIDOCANOL; SCLEROSING AGENT; TETRADECYL SULFATE SODIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ESTHETIC SURGERY; FEMALE; FOLLOW UP; HUMAN; HYPERPIGMENTATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SAFETY; SCLEROTHERAPY; TELANGIECTASIA; TREATMENT OUTCOME; ULCER; VARICOSIS; VEIN MALFORMATION;

ADULT; FACE; FEMALE; FOLLOW-UP STUDIES; HAND; HUMANS; MALE; MIDDLE AGED; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SODIUM TETRADECYL SULFATE; TELANGIECTASIS; THORAX; TREATMENT OUTCOME;

EID: 0036156807     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2002.01154.x     Document Type: Article

References (26)

1. Studies in cutaneous aging: I. The elastic fiber network
2. Histologic changes in skin associated with aging
3. The influences of age and sex on the skin thickness, skin collagen and density
4. Structural and functional changes of normal aging skin
5. Topical tretinoin therapy: Its use in photoaged skin
6. Tretinoin accelerates healing after trichloroacetic acid chemical peel
7. The role of sclerotherapy in abnormal varicose hand veins
8. The role of sclerotherapy in the rejuvenation of aging hands
9. Complications of sclerotherapy for vessels involving the hands and face
10. Treatment of telangiectasia: A review
11. The history of dermatology in American phlebology
12. Sclerotherapy for varicose and telangiectatic veins
13. Advances in sclerotherapy
14. Polidocanol (aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias
15. Hyperosmolar versus detergent sclerosing agents in sclerotherapy. Effect on distal vessel obliteration
16. Sclerosing agents in the treatment of telangiectasia
17. Extensive tissue necrosis following high concentration sclerotherapy for varicose veins
18. Inadvertent intra-arterial injection complicating ordinary and ultrasound-guided sclerotherapy
19. Complications of sclerotherapy
20. Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy
21. Determination of incidence and risk factors for postsclerotherapy telangiectatic matting of the lower extremity: A retrospective analysis
22. Influence of estrogens and progesterone on the venous system of the lower limbs in women
23. Estrogen and progesterone receptors. Their role in postsclerotherapy angiogenesis telangiectatic matting (TM)
24. Post-sclerotherapy compression: Controlled comparative study of duration of compression and its effects on clinical outcome